Cargando…
ANGPTL8 protein-truncating variant associated with lower serum triglycerides and risk of coronary disease
Protein-truncating variants (PTVs) affecting dyslipidemia risk may point to therapeutic targets for cardiometabolic disease. Our objective was to identify PTVs that were associated with both lipid levels and the risk of coronary artery disease (CAD) or type 2 diabetes (T2D) and assess their possible...
Autores principales: | Helkkula, Pyry, Kiiskinen, Tuomo, Havulinna, Aki S., Karjalainen, Juha, Koskinen, Seppo, Salomaa, Veikko, Daly, Mark J., Palotie, Aarno, Surakka, Ida, Ripatti, Samuli |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8109807/ https://www.ncbi.nlm.nih.gov/pubmed/33909604 http://dx.doi.org/10.1371/journal.pgen.1009501 |
Ejemplares similares
-
Obstructive sleep apnoea and the risk for coronary heart disease and type 2 diabetes: a longitudinal population-based study in Finland
por: Strausz, Satu, et al.
Publicado: (2018) -
Rare protein-altering variants in ANGPTL7 lower intraocular pressure and protect against glaucoma
por: Tanigawa, Yosuke, et al.
Publicado: (2020) -
Genetic predictors of lifelong medication-use patterns in cardiometabolic diseases
por: Kiiskinen, Tuomo, et al.
Publicado: (2023) -
Genome-wide association study of varicose veins identifies a protective missense variant in GJD3 enriched in the Finnish population
por: Helkkula, Pyry, et al.
Publicado: (2023) -
A data-driven medication score predicts 10-year mortality among aging adults
por: Häppölä, Paavo, et al.
Publicado: (2020)